| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 03/08/2011 | US7902226 Dehalogeno-compounds |
| 03/08/2011 | US7902225 Mycobacterial inhibitors |
| 03/08/2011 | US7902224 Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators |
| 03/08/2011 | US7902223 Phenyl derivatives as factor XA inhibitors |
| 03/08/2011 | CA2689051C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 03/08/2011 | CA2460313C Bisphenylsulfanyl and sulphonate compounds and use thereof for elevating hdl cholesterol levels |
| 03/03/2011 | WO2011024986A1 Organic electroluminescence device |
| 03/03/2011 | WO2011022928A1 Quinolines compounds, their preparation methods, pharmaceutical compositions containing the same and use thereof |
| 03/03/2011 | US20110053976 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 03/03/2011 | US20110053974 Carboxylic acid compound |
| 03/03/2011 | US20110053915 HETEROCYCLIC INHIBITORS OF AN Hh-SIGNAL CASCADE, MEDICINAL COMPOSITIONS BASED THEREON AND METHODS FOR TREATING DISEASES CAUSED BY THE ABERRANT ACTIVITY OF AN Hh-SIGNAL SYSTEM |
| 03/02/2011 | EP2289868A1 Carboxylic acid compound |
| 03/02/2011 | EP2288615A1 Selective caspase inhibitors and uses thereof |
| 03/02/2011 | EP2288595A2 An improved process for preparing montelukast and salts thereof |
| 03/02/2011 | EP2081904B1 Aripiprazole hemifumarate and process for its preparation |
| 03/02/2011 | EP1812394B1 Process for the preparation of montelukast and its salts |
| 03/02/2011 | EP1578715B1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 03/02/2011 | EP1001945B1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES |
| 03/02/2011 | CN101337933B Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 03/01/2011 | US7897774 Cyclic compound having quinolylalkylthio group |
| 03/01/2011 | US7897767 Oxime substituted imidazoquinolines |
| 03/01/2011 | US7897609 Aryl substituted imidazonaphthyridines |
| 03/01/2011 | US7897607 Cyclic compounds |
| 03/01/2011 | CA2602348C Cyclopentapyridine and tetrahydroquinoline derivatives |
| 02/24/2011 | WO2011021726A2 Nitrogen-containing compound and pharmaceutical composition |
| 02/24/2011 | WO2011021597A1 Quinoline derivative-containing pharmaceutical composition |
| 02/24/2011 | WO2011020886A1 Novel quinoline-hepcidine antagonists |
| 02/24/2011 | WO2010086860A3 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them |
| 02/24/2011 | US20110046599 Multi-Day Delivery Of Biologically Active Substances |
| 02/24/2011 | US20110046380 Method for producing unsaturated organic compound |
| 02/24/2011 | US20110046378 Novel Imaging Agents for Detecting Neurological Dysfunction |
| 02/24/2011 | US20110046177 Therapeutic quinoline and naphthalene derivatives |
| 02/24/2011 | US20110046146 Phosphodiesterase 4 inhibitors |
| 02/24/2011 | US20110046139 Benzocycloheptane and benzoxepine derivatives |
| 02/24/2011 | US20110046110 Quinolines and related analogs as sirtuin modulators |
| 02/24/2011 | US20110045100 Antimalarial Quinolines and Methods of Use Thereof |
| 02/24/2011 | US20110044913 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone hemi-fumarate |
| 02/24/2011 | CA2771579A1 Nitrogen-containing compound and pharmaceutical composition |
| 02/24/2011 | CA2771403A1 Quinoline derivative-containing pharmaceutical composition |
| 02/23/2011 | EP2287166A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 02/23/2011 | EP2287165A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 02/23/2011 | EP2287155A1 Acylthiourea compound or salt thereof, and use of the compound or the salt |
| 02/23/2011 | EP2287154A1 Efficient synthesis for the preparation of montelukast |
| 02/23/2011 | EP2287141A1 Method for producing unsaturated organic compound |
| 02/23/2011 | EP2285778A1 Nicotinamide derivatives |
| 02/23/2011 | EP2152699B1 Quinolone compound and pharmaceutical composition |
| 02/23/2011 | EP2066638B1 Process for the purification of montelukast |
| 02/23/2011 | CN1989108B Method for producing carbostyryl compound |
| 02/23/2011 | CN101981003A Amide compounds, compositions and uses thereof |
| 02/23/2011 | CN101979381A Method for refining crude quinoline by continuous rectification |
| 02/22/2011 | USRE42164 Hepatitis C inhibitor tri-peptides |
| 02/22/2011 | US7892775 Fluorescence assay for kinase activity |
| 02/22/2011 | CA2398163C Therapeutic morpholino-substituted compounds |
| 02/17/2011 | US20110040095 Preparation of montelukast and its salts |
| 02/17/2011 | US20110039888 Asymmetric alpha functionalization and alpha, alpha bisfunctionalization of aldehydes and ketones |
| 02/17/2011 | US20110039828 Tetrahydroquinoline derivatives and a process for preparing the same |
| 02/17/2011 | US20110039808 Multitarget Compounds Active at a PPAR and Cannabinoid Receptor |
| 02/17/2011 | US20110039802 Npy y5 antagonist |
| 02/17/2011 | US20110037063 Novel materils for organic electroluminescence device |
| 02/17/2011 | CA2771203A1 Treatment of bdnf-related disorders using laquinimod |
| 02/16/2011 | EP2284158A1 Quinoline compounds, pharmaceutical compositions, preparation methods and uses thereof |
| 02/16/2011 | EP2284157A1 Quinolines useful in treating cardiovascular disease |
| 02/16/2011 | EP2284149A1 Selective androgen receptor modulators and methods of use thereof |
| 02/16/2011 | EP2282995A1 Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors |
| 02/16/2011 | CN101432268B Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the ss2 adrenergic receptor |
| 02/15/2011 | US7888509 Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors |
| 02/15/2011 | US7888507 UV excitable fluorescent energy transfer dyes |
| 02/15/2011 | US7888356 Antibiotics containing borinic acid complexes and methods of use |
| 02/15/2011 | US7888136 Comprises benzazolium, pyridinium, or quinolinium connected by methine bridge; reporter molecules for detection of RNA in presence of DNA; solid phase synthesis; kits |
| 02/15/2011 | CA2689052C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 02/15/2011 | CA2478156C Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/15/2011 | CA2470067C Imidazoquinoline derivatives |
| 02/15/2011 | CA2459724C Multi-use multimodal imaging chelates |
| 02/15/2011 | CA2452445C Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 02/10/2011 | WO2011017519A2 Inhibitors of methionine aminopeptidases and methods of treating disorders |
| 02/10/2011 | WO2011017488A2 Combination of a selective ppar-gamma modulator and an incretin for the treatment of diabetes and obesity |
| 02/10/2011 | WO2011016648A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 02/10/2011 | WO2011016504A1 Nitrogenous-ring acylguanidine derivative |
| 02/10/2011 | WO2011015289A1 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl] amino]ethyl]-2(1h)-quinolinone hemi-fumarate |
| 02/10/2011 | US20110034692 Specific impurities of montelukast |
| 02/10/2011 | US20110034509 Beta-2-Adrenoreceptor Agonists |
| 02/10/2011 | US20110034439 Acylthiourea compound or salt thereof, and use thereof |
| 02/10/2011 | CA2770409A1 Nitrogenous-ring acylguanidine derivative |
| 02/09/2011 | EP2281823A2 Anti-inflammatory and analgesic piperidine derivatives |
| 02/09/2011 | EP1644321B1 New benzamides as ppaty modulators |
| 02/09/2011 | EP1379508B9 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 02/09/2011 | CN101967123A 2-cyclopropyl-4-(N-methyl substituted anilino) quinoline compound as well as intermediate, preparation method and application thereof |
| 02/08/2011 | US7884204 Phenylalanine derivatives |
| 02/08/2011 | US7884114 N-(4-{4-[(6-butyl-8-quinolinyl)oxy]-1-piperidinyl}butyl)ethanesulfonamide for treatment of allergic rhinitis |
| 02/08/2011 | US7884113 Eating and metabolism disorders; obesity; metabolism disorders; central nervous system disorders; analgesics; antiinflammatory agents; cognition activators |
| 02/08/2011 | US7884093 treating short cervix, increasing neonatal health |
| 02/08/2011 | CA2464214C Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them |
| 02/08/2011 | CA2442319C Carboxylic acid derivative and salt thereof |
| 02/08/2011 | CA2355717C 1,2-annelated quinoline derivatives |
| 02/03/2011 | WO2011014039A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 02/03/2011 | US20110028726 Method for preparing argatroban monohydrate and a process for its synthesis |
| 02/03/2011 | US20110028442 Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the beta2 adrenergic receptor |
| 02/03/2011 | US20110027716 Actinic-ray- or radiation-sensitive resin composition, compound and method of forming pattern using the composition |
| 02/03/2011 | US20110027178 Imaging the central nervous system |
| 02/03/2011 | US20110024691 Aromatic and aromatic/heteroaromatic molecular structures with controllable electron conducting properties |